Back to top
more

First Trust NASDAQ-100 Select Equal Weight ETF: (QQEW)

(Delayed Data from NASDAQ) As of Aug 21, 2026 04:00 PM ET

$164.41 USD

164.405
34,011

+1.25 (0.77%)

Volume: 34,011

Zacks ETF Rank

This is our ETF rating system that serves as a timeliness indicator for ETFs over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

See all the Top Ranked ETFs here - The complete list of all the top ranked ETFs

2 - Buy of 5   2      

After-Market: $164.34 -0.07 (-0.04 %) 7:58 PM ET

Zacks News

Sanghamitra Saha headshot

Nasdaq Hits 13,000 for the First Time: ETFs to Bet On

The year 2020 can easily be fully attributed to the Nasdaq as the tech-heavy index gained jumped about 44%. However, the index many more reasons to rally this year too.

Sanghamitra Saha headshot

Wil Nasdaq ETFs Win in 2021 After the Best Year Since 2009?

The Nasdaq clocked double-digit gains for two years in a row in 2020. It may log double-digit gains in 2021 all over again if the virus scenario does not improve as fast as expected.

    Sanghamitra Saha headshot

    Nasdaq in Correction: One Solid Reason to Buy the Dip in ETFs

    Vaccine makers' safety pledge for Covid vaccine means further uncertainty in the health emergency and the related economic recovery. This means further rally in tech stocks.

    Sweta Jaiswal, FRM headshot

    Ride the Relentless Big Tech Rally With These ETFs

    Strength in major players in the technological sector leads Nasdaq to another record-high closing.

    Sweta Jaiswal, FRM headshot

    Ride the Relentless Nasdaq Rally With These ETFs

    Major technology companies' resilience to the coronavirus crisis is supporting the Nasdaq index.

    Sanghamitra Saha headshot

    Nasdaq Hits Record Mark 11,000: Can ETFs Rally Further?

    The Nasdaq 100 has outperformed the Nasdaq composite with the former hitting the 11,267 mark on Aug 6 while the latter topping the 11,108-mark on the day.

    Sanghamitra Saha headshot

    Expect Further Rally in Nasdaq-100 ETFs as Moderna Joins

    Moderna shares have gained a whopping 283.6% this year due to successful early-stage clinical trials for COVID-19 vaccine, winning a place on the Nasdaq-100 with the company's sheer success.

    Sanghamitra Saha headshot

    Buy Growth ETFs on Endless Fed Support

    The first half of 2020 was extremely volatile for Wall Street due to the coronavirus outbreak but unprecedented stimulus measures by the Fed and government helped the S&P 500 to record the best second quarter ever in 2020.

    Sweta Jaiswal, FRM headshot

    Nasdaq Outperforms Major Indices in 1H20: ETFs to Gain

    It is widely believed that the major technology companies' resilience to the coronavirus crisis has supported the tech-heavy index.

    Sweta Jaiswal, FRM headshot

    Make the Most of the Big Tech Rally With These ETFs

    Strength in major players in the technological sector leads Nasdaq to eighth day of straight gains and a record-high closing.